These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 19557703)

  • 21. The pathogenic mechanisms of polyglutamine diseases and current therapeutic strategies.
    Bauer PO; Nukina N
    J Neurochem; 2009 Sep; 110(6):1737-65. PubMed ID: 19650870
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extrapyramidal signs are a common feature of spinocerebellar ataxia type 17.
    Lee WW; Kim SY; Kim JY; Kim HJ; Park SS; Jeon BS
    Neurology; 2009 Nov; 73(20):1708-9. PubMed ID: 19917997
    [No Abstract]   [Full Text] [Related]  

  • 23. Ophthalmic features of spinocerebellar ataxia type 7.
    Manrique RK; Noval S; Aguilar-Amat MJ; Arpa J; Rosa I; Contreras I
    J Neuroophthalmol; 2009 Sep; 29(3):174-9. PubMed ID: 19726937
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuro-ophthalmologic features of spinocerebellar ataxia type 7.
    Miller RC; Tewari A; Miller JA; Garbern J; Van Stavern GP
    J Neuroophthalmol; 2009 Sep; 29(3):180-6. PubMed ID: 19726938
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Complexins living up to their name--new light on their role in exocytosis.
    Stein A; Jahn R
    Neuron; 2009 Nov; 64(3):295-7. PubMed ID: 19914176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Severe epilepsy syndromes of early childhood: the link between genetics and pathophysiology with a focus on SCN1A mutations.
    Stafstrom CE
    J Child Neurol; 2009 Aug; 24(8 Suppl):15S-23S. PubMed ID: 19666879
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Novel human pathological mutations. Gene symbol: SCN1A. Disease: severe myoclonic epilepsy of infancy.
    Provenzano G; Mannarino E; Annesi F; De Marco EV; Rocca FE; Greco V; Scornaienchi V; Tarantino P; Civitelli D; Quattrone A; Tortorella G; Annesi G
    Hum Genet; 2009 Aug; 126(2):337. PubMed ID: 19694011
    [No Abstract]   [Full Text] [Related]  

  • 28. Protein kinase C gamma, a protein causative for dominant ataxia, negatively regulates nuclear import of recessive-ataxia-related aprataxin.
    Asai H; Hirano M; Shimada K; Kiriyama T; Furiya Y; Ikeda M; Iwamoto T; Mori T; Nishinaka K; Konishi N; Udaka F; Ueno S
    Hum Mol Genet; 2009 Oct; 18(19):3533-43. PubMed ID: 19561170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mental health: drop ideological baggage in favour of best tools.
    Arguello PA
    Nature; 2008 Aug; 454(7206):824. PubMed ID: 18704063
    [No Abstract]   [Full Text] [Related]  

  • 30. Advances in the identification and management of severe epilepsy syndromes of early childhood: focus on SCN1A.
    Douglass LM
    J Child Neurol; 2009 Aug; 24(8 Suppl):4S-5S. PubMed ID: 19666877
    [No Abstract]   [Full Text] [Related]  

  • 31. Stress: a dilemma concerning healthy CJD mutation carriers.
    Gigi A
    Isr Med Assoc J; 2009 Mar; 11(3):193. PubMed ID: 19544715
    [No Abstract]   [Full Text] [Related]  

  • 32. [Prerequisites for preimplantation genetic diagnosis (PGD in carriers of mutations responsible for hereditary cancers].
    Hüttelová R; Kleibl Z; Rezátová J; Krutílková V; Foretová L; Novotný J; Kotlas J; Zikán M; Pohlreich P
    Klin Onkol; 2009; 22 Suppl():S69-74. PubMed ID: 19764403
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characteristics of laryngeal cancer in BRCA-1 mutation carriers.
    Jaworowska E; Tarnowska C; Lubiński J; Serrano-Fernández P; Huzarski T; Górski B; Masojć B; Jakubiszyn J; Korytowska A; Kram A; Rabczynski J; Lubiński J
    Anticancer Res; 2009 Jul; 29(7):2703-5. PubMed ID: 19596949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advantages of the high resolution melting in the detection of BRCA1 or BRCA2 mutation carriers.
    Jiménez Ide J; Esteban Cardeñosa E; Palanca Suela S; González EB; Bolufer Gilabert P;
    Clin Biochem; 2009 Oct; 42(15):1572-6. PubMed ID: 19616529
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Factor V deficiency.
    Asselta R; Peyvandi F
    Semin Thromb Hemost; 2009 Jun; 35(4):382-9. PubMed ID: 19598066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of treatment with HVES on pain and electromyography activity in patients with TMD.
    Almeida AF; Berni KC; Rodrigues-Bigaton D
    Electromyogr Clin Neurophysiol; 2009; 49(5):245-54. PubMed ID: 19694212
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Investigation of the SPINK1 N34S mutation in Romanian patients with alcoholic chronic pancreatitis. A clinical analysis based on the criteria of the M-ANNHEIM classification.
    Diaconu BL; Ciobanu L; Mocan T; Pfützer RH; Scafaru MP; Acalovschi M; Singer MV; Schneider A
    J Gastrointestin Liver Dis; 2009 Jun; 18(2):143-50. PubMed ID: 19565042
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hemiconvulsion-hemiplegia syndrome in a patient with severe myoclonic epilepsy in infancy.
    Sakakibara T; Nakagawa E; Saito Y; Sakuma H; Komaki H; Sugai K; Sasaki M; Kurahashi H; Hirose S
    Epilepsia; 2009 Sep; 50(9):2158-62. PubMed ID: 19563349
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Spinocerebellar Ataxia Type 2: Clinicogenetic Aspects, Mechanistic Insights, and Management Approaches.
    Velázquez-Pérez LC; Rodríguez-Labrada R; Fernandez-Ruiz J
    Front Neurol; 2017; 8():472. PubMed ID: 28955296
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A comprehensive review of spinocerebellar ataxia type 2 in Cuba.
    Velázquez-Pérez L; Rodríguez-Labrada R; García-Rodríguez JC; Almaguer-Mederos LE; Cruz-Mariño T; Laffita-Mesa JM
    Cerebellum; 2011 Jun; 10(2):184-98. PubMed ID: 21399888
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.